Moderna begins COVID-19 vaccine trial in kids under age of 12 Moderna Inc. has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday. March 16, 2021 Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment